Mylan have issued a pharmacy level recall of all batches of Ranitidine Relief 150 mg and 300 mg tablets.
This means that there is no ranitidine available for collection from community pharmacy. People who have been prescribed ranitidine will need to contact their prescriber for an alternative treatment.
Alternative funded treatments:
Ranitidine is a type of medicine called an H2 antagonist. PHARMAC has secured a supply of famotidine as an alternative.
Proton pump inhibitor
Our clinical advice is that some patients may be able to be transitioned to a proton pump inhibitor. The currently funded proton pump inhibitors include:
H2 antagonist for people intolerant to proton pump inhibitors
For ranitidine patients who are intolerant to proton pump inhibitors, we've secured a supply of another H2 antagonist, Famotidine from Link Pharmaceutical, available in tab 20 mg (Pharmacode: 2580586) and 40 mg (Pharmacode: 2580594)
Please note that Famotidine Hovid has not been approved by Medsafe, so it will need to be supplied under Section 29 of the Medicines Act 1981.
Who to contact
For more information on the recall see information on the Medsafe website(external link)
Contact Mylan on 0800 579 811.
Last updated: 5 June 2020